Human serum potently induces hyphal development of the polymorphic fungal pathogen Candida albicans, a phenotype that contributes critically to infections. The fungal adenylyl cyclase Cyr1p is a key component of the cAMP/PKA-signaling pathway that controls diverse infection-related traits, including hyphal morphogenesis. However, identity of the serum hyphal inducer(s) and its fungal sensor remain unknown. Our initial analyses of active serum fractions revealed signs of bacterial peptidoglycan (PGN)-like molecules. Here, we show that several purified and synthetic muramyl dipeptides (MDPs), subunits of PGN, can strongly promote C. albicans hyphal growth. Analogous to PGN recognition by the mammalian sensors Nod1 and Nod2 through their leucine-rich-repeat (LRR) domain, we show that MDPs activate Cyr1p by directly binding to its LRR domain. Given the abundance of PGN in the intestine, a natural habitat and invasion site for C. albicans, our findings have important implications for the mechanisms of infection by this pathogen.
INTRODUCTION
Due to the AIDS pandemic, C. albicans has evolved from a largely harmless commensal to the most prevalent fungal pathogen in humans (Odds, 1985; Calderone and Fonzi, 2001; Gow et al., 2002; Klepser, 2006) . C. albicans often causes life-threatening systemic infections in immunocompromised patients. A remarkable trait of this fungus is its ability to switch between several growth forms such as budding yeast, pseudohyphae, and true hyphae in response to environmental cues (Berman and Sudbery, 2002) . The yeast-to-hypha transition facilitates tissue penetration and avoidance of phagocytic destruction in the host (Cutler, 1991; Lo et al., 1997; Phan et al., 2000) . C. albicans mutants defective in this growth transition exhibit greatly reduced virulence (Lo et al., 1997; Stoldt et al., 1997; Zheng et al., 2004) . Therefore, blocking the growth switch is widely thought to be a potential strategy for developing new therapies for candidiasis. Although a wide range of chemicals and growth conditions can trigger C. albicans hyphal growth, serum is indisputably the most potent and physiologically relevant (Gow, 1997; Ernst, 2000) . However, the identity of the inducer(s) and that of its sensor in C. albicans remain poorly defined. Feng et al. (1999) first found that most of the serum hyphainducing activity can pass through a dialysis membrane with a molecular weight cutoff of 1 kDa. Hudson et al. (2004) suggested that glucose is responsible for $80% of the serum activity. However, given the fact that hyphal induction is routinely performed in laboratories by using 5%-20% serum in media containing glucose at concentrations 10-to 20-fold higher than those found in normal serum, it cannot account for the serum activity.
A central signaling cascade for hyphal growth is the cAMP/ protein kinase A (PKA) pathway Rocha et al., 2001; Liu, 2002) . C. albicans has a single adenylyl cyclase Cyr1p. Hyphal induction activates this enzyme, increasing intracellular cAMP levels, which subsequently activates PKA (Bahn and Sundstrom, 2001; Rocha et al., 2001) . This pathway triggers the expression of hypha-specific genes involved in diverse infection-related functions including hyphal growth (Ernst, 2000; Lane et al., 2001; Liu, 2002; Zheng et al., 2004) . CYR1 deletion completely abolishes hyphal development and severely retards yeast growth (Rocha et al., 2001) . Recent studies suggest that Cyr1p may be involved directly in signal sensing. Klengel et al. (2005) reported that the catalytic domain of Cyr1p acts as a CO 2 sensor and thus mediates CO 2 -induced filamentous growth. A sensory role of Cyr1p was also suggested for quorum-sensing molecules (Hogan et al., 2004; Davis-Hanna et al., 2008) . However, the molecular details of signal sensing and the ensuing cyclase activation remain to be elucidated. In addition to the cyclase domain, Cyr1p contains two other conserved domains: an N-terminal RAS-association (RA) domain and a middle domain composed of 14 leucine-rich repeats (LRRs). Long-LRR domain is a key feature of several protein families involved in innate immunities in mammals, insects, and plants that recognize distinct pathogen-associated molecular patterns (PAMPs), such as peptidoglycans (PGNs), lipopolysaccharides, and lipoproteins (Inohara and Nuñ ez, 2003a; Philpott and Girardin, 2004) . Substantial evidence suggests that LRR domains have a direct role in ligand sensing. Particularly relevant to this work are two mammalian bacterial sensors Nod1 and Nod2 that use their LRR domain to recognize PGN fragments with a minimal structure of g-D-glutamyl-meso-DAP and N-acetylmuramyl-L-alanine-D-isoglutamine, respectively (Girardin et al., 2003b; Inohara et al., 2003b) .
In this study, we have attempted to identify and characterize the hypha inducers in serum and their sensor in C. albicans. We detected PGN-like molecules in chromatographic fractions of serum enriched for hypha-inducing activities. By purification and chemical synthesis, we found that several PGN motifs exhibited exceedingly potent hypha-inducing activities. We also provide compelling evidence that PGN-derived molecules can directly bind to the LRR domain of Cyr1p, stimulate cAMP production, and promote hyphal growth. Our findings have identified a potentially important host-associated virulence factor and its sensor in the pathogen.
RESULTS

Detection of PGN-like Molecules in Serum Fractions
Active for Hyphal Induction To identify the hyphal inducer(s) in serum, we performed a series of chromatographic fractionations of human plasma and bovine serum filtrates and tracked the inducing activity by treating 5 3 10 5 yeast cells/ml at 37 C in Hank's buffered salt solution (HBSS) ( Figure 1A ), a condition empirically found to allow low-background hyphal growth (Fang and Wang, 2006) . Our studies on human plasma and bovine serum yielded similar results. In the last purification step using reversed-phase high performance liquid chromatography (HPLC), high activities were eluted between 9 and 14 min ( Figure 1B ). When pooled, this sample (F9-14) induced >90% hyphal growth at concentrations of $0.1 mg dry material per ml compared with $1.5 mg/ml of the starting filtrates for similar levels of induction. However, further resolution of the active components proved difficult because the activity was always distributed broadly. We then subjected F9-14 to NMR analysis, which revealed considerable amounts of glucose, fructose, glycerol, and lactic acid (data not shown). However, these molecules exhibited no significant hypha-inducing activity singly or in combination. The NMR data also suggested structures resembling muramic acid (Mur), alanine (Ala), and isoglutamine (iGln). Mur is a hallmark of bacterial PGN in nature, and iGln is a common amino acid found in the oligopeptides that crosslink the glycan strands (Shockman and Barrett, 1983; Cloud-Hansen et al., 2006) . We thus proposed a structure Mur-L-Ala-D-iGln (MAiGn) based on the highly conserved PGN subunit MurNAc-L-Ala-D-iGln (MNAiGn) ( Figure 1C ). In this paper, these two molecules and their derivatives are collectively referred to as MDPs for muramyl dipeptides. Later, comparisons of the NMR data of F9-14 with that of pure MAiGn supported this proposal (see below and Tables S1 and  S2 ). MDPs are well-known signaling molecules that can trigger a range of physiological responses in mammals and mediate bacterial interactions with diverse organisms (Johannsen et al., 1990; Koropatnick et al., 2004; Cloud-Hansen et al., 2006) .
Purified and Synthetic MDPs Exhibit Strong
Hypha-Inducing Activity Next we obtained PGNs from the Gram-negative Escherichia coli and the Gram-positive Staphylococcus aureus to test whether they can induce C. albicans hyphal growth. While polymeric PGNs at concentrations up to 10 mg/ml exhibited no such activity, their partial hydrolysis with HCl produced molecules (filtrate < 3 kDa) that induced >90% true hyphae at concentrations as low as 15 mg/ml ( Figure 1D ). In contrast, the hydrolysis products > 3 kDa were not active at concentrations up to 10 mg/ml (data not shown). The results suggest that certain PGN-derived molecules are potent inducers for C. albicans hyphal growth. However, due to the exceedingly high complexity of the PGN lysates, it was difficult to identify and purify individual active molecules. Alternatively, we synthesized MAiGn (see Supplemental Data). Strikingly, this compound exhibited a strong, concentration-dependent activity, causing 50% (I 50 ) of true hyphae at $15 and $31 mM in glucose minimal medium (GMM) and HBSS, respectively ( Figure 2A ). Furthermore, MNAiGn (commercially available) was also active but with an I 50 of $3-4 mM. N-acetylglucosamine (GlcNAc), another conserved PGN component long known to be a strong hyphal inducer (Simonetti et al., 1974) had an I 50 of $1.8 mM. Mur, L-Ala, and D-Glu at concentrations up to 10 mM are not active for hyphal induction either individually or when mixed at equal molar concentrations (data not shown).
In search of an economical way to obtain MAiGn, we found that treating MNAiGn (m/z = 493 Da as M + 1 in mass spectrometry [MS] ) with 1N HCl at room temperature for 16-20 hr could generate hydrolysates that cause hyphal growth at nanomolar concentrations in both liquid and solid media (Figures 2A and 2B ). Liquid chromatography (LC)/MS analyses of the lysates revealed two major products with m/z of 452 and 494 Da, corresponding to Mur-L-Ala-D-Glu and MurNAc-L-Ala-D-Glu, respectively ( Figure S1 ). Among many minor hydrolysis products, one 476 Da ion was identified to be 1,6-anhydro-Mur-L-Ala-D-Glu (see Supplemental Data). We purified and tested these three compounds for hyphal induction. Figure 2A shows that 1,6-anhydro-Mur-L-Ala-D-Glu, Mur-L-Ala-D-Glu, and MurNAc-L-Ala-DGlu exhibited I 50 s of 2.3, 5.8, and 32.3 mM in HBSS, respectively. These compounds were also active in GMM with somewhat different I 50 s. However, none of them was more active than the crude lysates, suggesting that either the lysates contain unidentified, more active compounds or that multiple compounds act synergistically. Mixing the purified compounds in various ratios never resulted in activities higher than the most active individual component (data not shown). Currently, we cannot distinguish between the two possibilities because of the great difficulty and cost to obtain sufficient amounts of most of the minor hydrolysis products. Nonetheless, our data strongly support the conclusion that certain PGN-derived molecules are potent inducers for C. albicans hyphal growth.
Confirmation of Mur-Containing Compounds in Serum
Previous studies suggested that PGNs can enter the blood stream through the intestinal epithelium (Sartor et al., 1987 (Sartor et al., , 1988 . Strong evidence for the presence of PGN-derived molecules in blood came from the isolation from human urine of the tracheal cytotoxin, a monomeric unit of PGN produced by certain Gram-negative bacteria (Krueger et al., 1982; Martin et al., 1984; Cloud-Hansen et al., 2006) . To confirm the presence of PGN-derived molecules in serum, we did the following. Serum filtrates were hydrolyzed with HCl to release Mur and then treated with sodium borohydride to destroy by reduction the anomeric center of the sugar ring, which splits chromatographic peaks and thus complicates analysis (see Figure S1 ). The reduced Mur was then modified by adding a fluorescent dansyl group at the single NH 2 group to facilitate detection by HPLC. Commercial Mur processed in the same way was used as standard. After dansylation, the samples were separated by HPLC and the fraction matching the retention time of the standard was collected for MS. Ions matching reduced dansyl Mur (m/z = 487.1 and 469.1 [À 1 H 2 O]) were detected in all five independent serum samples tested ( Figures 3A and 3B ). These ions were undetectable if the hydrolysis step was omitted ( Figure 3C ), suggesting that Mur in serum is present as part of larger molecules. Further bombardment of the 487.1 ion generated a subset of ions matching those derived from the standard ( Figure 4A ). Thus, the results strongly support the presence of Mur-containing compounds in serum. Contamination of serum by PGNs during experiments is unlikely because pure water processed using the same protocol did not yield any of the characteristic ions (data not shown). To estimate the amount of Mur in serum, we used sodium borodeuteride, instead of sodium borohydride, to reduce standard Mur, which increased the mass of the reduced Mur by 1 Da. Known amounts of the heavier Mur were then added to serum filtrates that had been hydrolyzed with HCl and reduced with sodium borohydride.
After dansylation, the samples were resolved by HPLC and the fraction containing dansyl Mur was analyzed by MS ( Figure 4B ). Comparing the relative intensities of 487.1 and 488.1 ions, the concentration of Mur was estimated to be at least 0.1-0.5 mM in the five serum samples tested. PGNs have also been detected in various mammalian tissues in previous studies, although not quantified (Sen and Karnovsky, 1984; Lehtonen et al., 1997; Schrijver et al., 2001 ).
The LRR Domain of Cyr1p Is Required for C. albicans Response to MDPs PAMPs are recognized by pattern-recognition receptors (PRRs) in diverse organisms (Royet and Dziarski, 2007) . For example, the mammalian innate immunity proteins Nod1 and Nod2 recognize PGN motifs (Girardin et al., 2003a (Girardin et al., , 2003b . PRRs commonly contain a LRR domain for ligand binding (Philpott and Girardin, 2004; Royet and Dziarski, 2007) . We speculated that C. albicans might use a similar mechanism for MDP sensing. Using the LRR sequences of Nod1 and Nod2 to search the C. albicans genome database (www.candidagenome.org) scored a strong match Table S5 for all strains used) were incubated in HBSS with or without 5% serum filtrate at 37 C for 2 hr. The use of G1 cells was to ensure uniform hyphal growth, allowing more accurate differentiation of the activities of various hypha-inducing compounds as described in later experiments. Bars indicate 5 mm.
(B) The upper panel shows a chromatograph of reversed-phase HPLC separation of serum. To track the hypha-inducing activity, 10 ml of each fraction was added to 40 ml of HBSS containing yeast cells at 5 3 10 5 cells/ml and then incubated at 37 C for 2 hr (lower panel).
(C) A proposed compound (left) based on the NMR data (see Supplemental Data) and a subunit of typical bacterial PGN (right).
(D) E. coli and S. aureus PGNs were hydrolyzed with HCl, passed through a 3 kDa filter, and lyophilized before testing for hyphal induction in HBSS for 2 hr. Bar indicates 5 mm.
Cell Host & Microbe
Peptidoglycan Induces Candida albicans Hyphal Growth with the adenylyl cyclase Cyr1p that contains 14 LRRs organized in three clusters from amino acid (aa) 489 to 898 ( Figure 5A ). To determine whether the LRR domain is required for MDP sensing, we first created a series of mutant versions of Cyr1p deleted for either the entire LRR domain (cyr1-lrrD) or one of the LRR clusters (cyr1-c1D, cyr1-cl2D, and cyr1-cl3D). We also created two mutants in each of which two highly conserved residues in a single repeat in the middle of clusters 1 and 2 were replaced with Ala: they are cyr1-2AA and cyr1-9AA, carrying Leu / Ala and Asn / Ala mutations in repeats 2 and 9, respectively ( Figure 5A ). The genomic DNA fragment containing the entire CYR1 coding sequence and 5 0 -and 3 0 -flanking regions was cloned in the plasmid CIp10 (Murad et al., 2000) as template for mutagenesis. Each construct was linearized at a unique MluI site within the promoter and transformed into the cyr1D mutant for integration at the chromosomal CYR1 promoter. Correct synthesis of the proteins was verified by western blotting using a mouse antiserum raised against the PP2C domain ( Figure 5B ). The wild-type CYR1 fully restored hyphal growth in cyr1D and reduced the doubling time of yeast growth from 4.46 hr to 1.67 hr ( Figure 5C ). In contrast, none of the domain-deletion mutants significantly restored hyphal growth (data not shown), although they reduced the yeast doubling time to $2 hr. Moreover, the cyr1-2AA and cyr1-9AA alleles could also restore the yeast growth without significantly improving hyphal growth. The data thus indicate that the LRR domain is essential for hyphal growth.
The LRR Domain of Cyr1p Directly Binds MDPs
Next we asked whether MDPs can bind to the LRR domain of Cyr1p. We biotinylated (Bt) MNAiGn at the single COOH group of iGln and then bound Bt-MNAiGn to streptavidin agarose beads. The beads were incubated with the LRR domain of Cyr1p (aa 480-900) that was expressed in E. coli and purified as a GST fusion protein (GST-LRR), and for control, the same region containing the 9AA mutation (GST-9AA) was similarly prepared ( Figure 5D ). The GST-LRR proteins bound to the beads were detected by anti-GST western blotting. With equal amounts of the input proteins, the beads carrying Bt-MNAiGn pulled down $10 times more of GST-LRR than GST-9AA ( Figure 5E ). As a control, streptavidin beads without bound Bt-MNAiGn did not pull down any GST-LRR. To gain more robust results, we tested whether preincubating GST-LRR with MNAiGn or MAiGn can block the pull-down. We preincubated GST-LRR with different amounts of the two compounds for 60 min before adding the Bt-MNAiGn beads. Then, GST-LRR both on beads (bound) and in supernatants (unbound) were probed by western blotting. We found that both MNAiGn and MAiGn blocked the pull-down in concentration-dependent fashions ( Figure 5F ). Strikingly, MAiGn is much more effective than MNAiGn, consistent with the observed large difference between the two compounds in hyphainducing activities shown in Figure 2A . We further tested whether
MDPs can bind to Cyr1p in cell lysates. We constructed a C. albicans strain expressing a version of Cyr1p with an N-terminal HFM tag (His-Flag-Myc) (Sinha et al., 2007) under the control of the MET3 promoter. Cell lysates from this strain were mixed with the streptoavidin beads with or without bound Bt-MNAiGn. HFM-Cyr1p was then detected by anti-Myc western blotting. Figure 5G shows that the beads with bound Bt-MNAiGn pulled down from the HFM-Cyr1p-containing lysate an $200 kDa protein that matches the predicted size of HFM-Cyr1p. This interaction was blocked by preincubating the lysates with MAiGn. Figure 5H ). Then, we repeated the assay using a fixed concentration of 3 H-MNAiGn (200 mM) and quantified the uptake over time. The results showed a timedependent increase in intracellular 3 H ( Figure 5I ). Together, the data support the idea that MDP can enter the cell. However, it remains possible that 3 H enters the cell after the breakdown of 3 H-MNAiGn. To address this, we used MS to determine whether intact MNAiGn molecules can be detected in lysates of cells grown in the presence of MNAiGn at 30 C for 30 min. Duplicate cultures were kept on ice for 30 min as negative controls. Cells were washed extensively before lysis in the presence of 0.04% TFA (to reduce binding of MDP to proteins). The lysates were filtered to remove proteins before HPLC separation. Fractions corresponding to the control MNAiGn were collected for MS analysis. Ions with m/z of 493.2 and 475.2, matching MNAiGn and MNAiGn À1 H 2 O respectively, were detected only in cells cultured at 30 C but not in those kept on ice ( Figure S2 ), indicating that intact MNAiGn molecules can enter the cell. Although C. albicans can take up MDPs, the compounds cannot support cell growth as the sole carbon or nitrogen source in media ( Figure S3 ).
Recent reports suggested that the intestinal apical di/tripeptide transporter, hPepT1, may be responsible for MNAiGn uptake (Vavricka et al., 2004; Ismair et al., 2006) . C. albicans contains two hPepT1 homologs encoded by orf19.6937 and orf19.2583. However, our unpublished data showed that mutants deleted of both genes were normal in both 3 H-MNAiGn uptake and hyphal growth. Another possible candidate for MDP transporter is the GlcNAc transporter NGT1 found in C. albicans by Alvarez and Konopka (2007) . But gene deletion had no significant effect on 3 H-MNAiGn uptake and hyphal growth either (data not shown). Thus, the mechanism for MDP uptake in C. albicans remains to be elucidated.
MDPs Activate the Cyclase Activity of Cyr1p
When C. albicans yeast cells are exposed to hyphal induction, intracellular cAMP levels rise transiently ; Rocha et al., 2001) . We next asked whether the LRR domain is required for cAMP production. While cyr1D cells could not produce cAMP, reintroducing a copy of cyr1-lrrD or cyr1-9AA restored the cAMP level to $1.2-1.6 pmol per mg of dried cells compared to $1.8 pmol for wild-type ( Figure 6A ). In response to hyphal induction, wild-type cells increased the cAMP level to $3.8 pmol after 20-30 min. In contrast, cells expressing Cyr1p-lrrD or Cyr1p-9AA exhibited only a slight increase, indicating that the LRR domain is critically required for raising cellular cAMP levels upon hyphal induction. To further confirm that MAiGn enhances the adenylyl cyclase activity, we measured the conversion of a-32 P-ATP to 32 P-cAMP in mechanically disrupted cells in the presence of different amounts of MAiGn. We found that $5 mM of the compound was sufficient to maximally activate the production of 32 P-cAMP in disrupted wild-type cells ( Figure 6B ), whereas no activation was observed in disrupted cyr1D or cyr1-9AA cells ( Figure 6C) . The results are consistent with the idea that the MDP-LRR interaction directly enhances the adenylyl cyclase activity of Cyr1p.
Synergistic Effects of MDPs and CO 2
Previous studies showed that bicarbonate, the hydrated form of CO 2 , can activate the recombinant catalytic domain of Cyr1p by >20-fold in vitro, presumably responsible for the CO 2 -induced filamentous growth (Klengel et al., 2005) . Next, we wished to know whether CO 2 may act synergically with MDPs. First, we compared hyphal growth induced with different concentrations of MDPs either in the atmospheric air or in 5% CO 2 . Figure 7A shows that hyphal growth was markedly stronger in the presence of CO 2 . For example, 5% CO 2 or 20 mM MAiGn alone caused little hyphal growth after 3 hr of induction, whereas combining the two resulted in >80% of true hyphal growth, consistent with a synergistic effect. Similar synergy was also observed between 5% CO 2 and 0.5-5 mM MNAiGn (data not shown). Although 5-20 mM bicarbonate could also induce strong hyphal growth, the synergy with MDPs was not obvious (data not shown). Next, we wanted to determine whether bicarbonate and MDPs have any synergistic effects on cellular cAMP levels and the activity of Cyr1p. We found that induction with 10 mM bicarbonate produced a spike in cAMP cellular levels, which Figure 3B were further fragmented in the second round of MS. The proposed structures of the common ions (a-f) are shown. (B) Mur in serum was reduced with sodium borohydride. Then the sample was spiked with known amounts of standard Mur that had been reduced with borodeuteride (D-Mur). Dansylation, HPLC, and MS were then done as described in Figure 3 . The result is representative of serum samples from five healthy people of 25-30 years of age.
peaked at $15 min compared to $30 min under serum induction ( Figure 7B ). However, the peak levels detected were similar under the two conditions. Induction with both bicarbonate and serum delayed the peak to $45 min without significant effects on the peak level of cAMP. We did not examine the effect of MDPs on cellular cAMP levels due to the inhibitive cost of the large amounts of the compounds required for such experiments. Alternatively, we performed the adenylyl cyclase activity assay using cell lysates as described in Figures 6B and 6C . The results show that although serum, MAiGn, and bicarbonate all can activate cAMP synthesis, no synergy was observed between bicarbonate and serum or MAiGn in enhancing the cyclase activity After overnight incubation at 4 C, the beads were precipitated by centrifugation. Then, GST-LRR both on beads (bound) and in supernatants (unbound) was detected by anti-GST western blotting. ( Figure 7C ). Together, the mechanisms for the synergy of CO 2 and MDPs in promoting the hyphal growth are apparently more complex than simply increasing the cyclase activity of Cyr1p. Consistently, Davis-Hanna et al. (2008) observed that although cells expressing the hyperactivated Ras G13V exhibit constitutive filamentous growth, their cellular cAMP levels were 2-to 2.5-fold lower than wild-type cells, suggesting that the status of hyphal growth is not always correlated with high cAMP levels.
RAS1 Is Required for Optimal Response to MDPs
Ras1p is thought to be an upstream regulator of Cyr1p ) and ras1D/D mutants are defective in hyphal growth (Feng et al., 1999; Leberer et al., 2001; Fang and Wang, 2006) , thereby challenging our hypothesis of the Cyr1 LRR domain being the sensor. We next examined whether RAS1 is required for the MDP-induced hyphal growth. We found that although the ras1D/D cells responded poorly to low concentrations of MDPs, they exhibited significant filamentous growth, even true hyphal growth in the presence of high concentrations of the inducers. An example is shown in Figure 7D . After a 3 h induction with 40 mM Mur-L-Ala-D-Glu (I 50 = $6 mM, see Figure 2 ), $40% of the ras1D/D cells formed true hyphae while the rest were in pseudohyphal or yeast form. The mutant also exhibited increased filamentous growth in response to greater concentrations of serum. A mutant expressing a version of Cyr1p with the RA domain deleted (Fang and Wang, 2006) yielded similar results (data not shown). The data indicate that while lacking Ras1p greatly reduces the cell's sensitivity to the hyphal inducers, it does not completely abolish it. Weak filamentous growth in serum-containing media was also shown in previous reports (Feng et al., 1999; Leberer et al., 2001) . Together with the well-established Ras association with adenylyl cyclases in yeast (Toda et al., 1985; Fang and Wang, 2006) , we propose that Ras1p and Cyr1p work as a complex that constitutes part of a sensor/effector machinery, and their interaction ensures proper protein folding for optimal ligand sensing and/or subsequent allosteric activation of the catalytic domain. Without Ras1p the system functions partially, thereby requiring strong inducing signals to activate downstream events for hyphal growth. This model explains our observations above. However, we cannot rule out the possibility that signal sensing may also occur upstream of Ras1p.
DISCUSSION
Serum is a strong inducer for the yeast-to-hypha transition in C. albicans, a well-proven virulence trait. Therefore, identification and characterization of the inducing entities in serum and understanding their mechanisms of action will impact the development of therapies for one of the most common infectious diseases. In this study, we first observed by NMR analysis signs of PGN-like molecules in chromatographic fractions of serum highly active for hyphal induction. Later, we confirmed that several purified and synthetic MDPs indeed exhibited such activity. Strikingly, some of these molecules are 100-to 1000-fold more potent than any other compounds documented so far for hyphal induction in C. albicans. Prompted by current understanding of mechanisms for PGN sensing by LRR domains of some PRRs in mammals, we obtained compelling evidence that C. albicans senses MDPs using the LRR domain of the adenylyl cyclase Cyr1p. Deleting either the entire or part of the LRR domain or mutating some of the highly conserved residues in a single repeat abolished the postinduction cAMP spike and blocked hyphal growth. Moreover, we showed that MDPs can bind to the LRR domain in vitro and Cyr1p in cell lysates. The importance of our findings is manifold. First, we reveal a host-associated factor, namely PGN-derived molecules that may play a previously unknown yet potentially important role in C. albicans infections. Second, we provide key insights into the mechanisms of signal sensing for C. albicans hyphal growth. Third, our findings suggest that the recognition of PGNs by the LRR domain may represent an ancient mechanism that perhaps first evolved as a means for fungal cells to monitor and respond to bacteria. Fourth, our findings disclose potential targets for developing novel anti-Candida therapies.
We propose that MDPs act as allosteric regulators of the Cyr1p cyclase by binding to the LRR domain. This design principle with both the signal sensor and the catalytic domain in the same protein is conserved in the class III family of adenylyl cyclases to which Cyr1p belongs (Linder and Schultz, 2003) . Members of this family typically have a C-terminal catalytic domain and multiple N-terminal domains. These N-terminal domains play regulatory roles by serving as sensors for various ligands/ signals (Linder and Schultz, 2003) . Cyr1p orthologs have been found in all fungi whose genome sequences are available. Figure S4 shows the domain organization of adenylyl cyclases from 30 fungi. These proteins are highly conserved in domain organization and invariably contain 11-16 LRRs near the center. However, data on LRR's role in regulating the cyclase activity remain strikingly limited. In recent years, it has rapidly become clear that a key feature of many proteins involved in innate immunities, such as the Toll-like receptors in animals (Royet and Dziarski, 2007) and the R proteins in plants (Takken et al., 2006) , is the presence of long LRR domains. Substantial evidence is available strongly supporting the idea that the LRR domains function as sensors for diverse microbial molecules. A prominent example is the mammalian bacterial sensors Nod1 and Nod2: they bind distinct PGN-motifs, including MNAiGn, leading to the activation of immune responses (Girardin et al., 2003a (Girardin et al., , 2003b Inohara and Nuñ ez, 2003a; Inohara et al., 2003b; Philpott and Girardin, 2004) . Taken together, the mechanisms for class III adenylyl cyclase regulation and the roles of LRR domains in recognizing PAMPs are consistent with our findings and support our proposal that the LRR domain of Cyr1p is a sensor for MDPs. However, we cannot rule out the possibility that the LRR domain may also sense other hypha-inducing molecules. Given the conserved roles of the Cyr1p family of adenylyl cyclases in regulating cellular responses to environmental conditions, it would be interesting to find out whether the role of LRR domains in signal sensing are ubiquitous in fungi. The fungal LRR domains shown in Figure S4 share 22% to 94% amino acid identities and contain different number of repeats with distinct clustering patterns. This feature underlies an enormous structural diversity, which may play a role in determining the specificity of signal sensing. Mammals are not known to be able to synthesize Mur. Then, where do the Mur-containing molecules in serum come from? The human intestinal mucosa harbors $10 14 of bacteria belonging to $500 species, which produce abundant, structurally diverse PGN-derived molecules (O'Hara and Shanahan, 2006) . In addition, the intestinal epithelium is the largest microbe-host interface in the human body where bacteria are constantly sampled and degraded by specialized immune cells (Kelly et al., 2005) . Experiments in rats have shown that PGNs can enter the circulation system through the intestinal epithelium (Sartor et al., 1987 (Sartor et al., , 1988 . Thus, intestinal bacteria are the most likely source of Mur-containing molecules in serum. Because C. albicans colonize the gastrointestinal track, it should be of high importance to learn about how C. albicans responds to MDPs in its natural habitat and how this contributes to its invasion of the epithelium.
So far, we have only been able to infer the presence of MDPs in serum based on the detection of Mur. The inherent high-PGN heterogeneity of bacterial species together with many possible ways of PGN degradation by both the producers and the host is expected to produce a complex repertoire of PGN-derived molecules. Therefore, it is highly likely that MDPs in serum are present in many forms and each at low concentrations. Compounded with the high chemical complexity of serum and the unfavorable chromatographic properties of sugars, it is currently technically challenging to purify each of the PGN-derived molecules for structural elucidation.
Our findings reveal a mechanism for fungi to sense and react to bacteria, which have important implications in understanding the basis of C. albicans infections as well as how other fungal species respond to environmental signals.
EXPERIMENTAL PROCEDURES
Isolation of the Hypha-Inducing Factors from Bovine Serum and Human Plasma Aliquots of bovine serum (Hyclone, Logan, UT) or human plasma (local hospitals) were first passed through a C 18 cartridge (Waters Co., Milford, MA) to remove highly nonpolar components. Then trifluoroacetic acid (TFA) was slowly added in by vigorous stirring to a final concentration of 0.1%. The solution was filtered by using a Centriplus membrane (Millipore, Billerica, MA) with 3 kDa cutoff. Then, 200 ml of the filtrate was applied to an Amersham Superdex Peptide HR 30/10 gel filtration column (Amersham, Buckinghamshire, UK) for separation by FPLC (Amersham). Mobile phase was 0.04% TFA in H 2 O and flow rate was 0.6 ml/min. Fractions of 0.6 ml were collected and tested for hyphal induction. The highest activity was eluted at 20-22 min. These fractions were pooled, lyophilized, and resuspended in 0.04% TFA before reversed-phase HPLC (Waters) using a PrepNova-PakHR C 18 column (7.8 3 300 mm). Solvent A was 0.04% TFA in water and B was 0.04% TFA in acetonitrile. A linear gradient was used: 0-0.5 min, 5% B with the flow rate increased from 0 to 2.0 ml/min; 0.5-10 min, 5% B; 10-45 min, 5% to 50% B; 45-50 min, 50%-5% B; 60-60.1 min, 5% B; and the flow rate was reduced from 2.0 to 0 ml/min.
Detection and Quantification of Mur in Serum
Human serum samples were donated by three male and two female healthy volunteers of 25-30 years of age. To release Mur from PGN, 500 ml of serum filtrate were lyophilized, resuspended in 4 N HCl, and hydrolyzed at 90 C for 3 hr. The hydrolysis product was dried in a Savant Speed Vac and then dissolved in 100 ml of 400 mM sodium borate (pH 9.6) with the pH adjusted to $8.5 with NaOH. To reduce the sugar ring of Mur, 100 ml of borohydride (20 mg/ml) was added for reaction at RT for 2 hr. Excess borohydride was destroyed by adjusting pH to 4 with phosphoric acid. Then 400 ml of borate buffer (400 mM, pH 9.6) was added and the pH adjusted to 8.5 with NaOH. To dansylate Mur, 12.95 mg of dansylchoride in 600 ml acetone were added and the reaction incubated at RT overnight. The sample was dried first in Speed Vac to remove acetone followed by lyophilization and resuspension in 200 ml of 5% acetonitrile and 0.04% TFA. For control, 5 mg of Mur (Sigma-Aldrich) in 500 ml H 2 O were similarly processed. The above processed samples and standard Mur were resolved by HPLC using a Waters SunFire C 18 reverse-phase column (4.6 3 150 mm, 3.5 mm) with a UV-VIS detector set at 204 nm. The flow rate was 0.8 ml/min. Solution A was 0.04% TFA in H 2 O, and B was 0.04% TFA in acetonitrile. At 0, 25, 30, 40, and 45 min, the percentage of solution B was 11, 11, 50, 50, and 11, respectively. The fractions corresponding to the standard dansyl Mur was collected for mass spectrometry.
Preparation of Bacterial Peptidoglycan
High-purity PGN was prepared by combining previous protocols by Popham et al. (1996) and Koehl et al. (2004) . E. coli was grown in nutrient broth for 24 hr and harvested by centrifugation. The pellet was washed 33 with PBS before lyophilization. Eight-hundred milligrams of the lyophilized cells were resuspended in 15 ml of extraction buffer containing 50 mM Tris-HCl (pH 8.0), 4% SDS (w/v), 30 mM DTT, and 2 mM EDTA; incubated in a 100 C water bath for 20 min; and then shifted to 37 C for 40 min. The sample was centrifuged at 13,000 g for 30 min, and the pellet was resuspended in 37 C distilled water. This wash was done 53 to remove SDS before resuspending the pellet in 6 ml of 50 mM Tris-HCl (pH 7.0) containing 12 mg pronase and incubated at 37 C for 1 hr. Pronase was inactivated by heating at 60 C for 90 min. The
Cell Host & Microbe
Peptidoglycan Induces Candida albicans Hyphal Growth sample was centrifuged at 27,000 g for 30 min, and the pellet was resuspended in 50 mM Tris-HCl (pH 7.0) containing 4% SDS (w/v), 30 mM DTT, and 2 mM EDTA, and incubated in a 100 C water bath for 20 min. The sample was then washed 73 in 37 C distilled water. After each wash, PGN was spun down at 160,000 g for 4 hr. S. aureus PGN was purchased from Sigma-Aldrich.
C. albicans Growth Conditions
The strains were routinely grown in YPD (2% yeast extract, 1% bactopeptone, and 2% glucose) or GMM (2% glucose, 6.79 g/l yeast nitrogen base without amino acid). For hyphal growth, yeast was incubated at 37 C in GMM or HBSS containing 10% serum or various amounts of hypha-inducing compounds. HBSS contains 80 g NaCl, 4 g KCl, 10 g glucose, 600 mg KH 2 PO4, and 475 g Na 2 HPO 4 (pH7.2) in 1 L of H 2 O. For hyphal growth on solid media, serum or a compound was added to melted solid media at 50 C. For yeast culture, cells were grown at 30 C. G 1 cells were obtained by elutriation using a Beckman (Fullerton, CA) JE elutriator.
CYR1 Expression and LRR Domain-Deletion Constructs
To generate the plasmid for expressing CYR1, the ORF with 550 bp promoter and 630 bp 3 0 untranslated region was PCR amplified and cloned into CIp10 (Murad et al., 2000) . Restriction sites were added in the PCR primers for cloning. This plasmid was also used for introducing LRR domain mutants. For domain deletion, the CYR1 regions flanking the segment to be deleted were PCR amplified and recloned into CIp10 without disrupting the reading frame. The QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA) was used to create point mutations. Each of the CYR1 constructs was linearized at a unique MluI site in the promoter and integrated at the CYR1 locus in the cyr1D mutant.
Intracellular cAMP Assay
This assay followed the methods of Rocha et al. (2001) and Jung and Stateva (2003) with modifications. For hyphal induction, yeast cells were grown in YPD at 30 C to OD 600 = 1.5, harvested by centrifugation, washed 23 with HBSS, and then resuspended to 1.25 3 10 8 cells/ml in HBSS containing 25% serum.
Cells were incubated at 37 C with shaking, and 20 ml aliquots were harvested at intervals. Cells were immediately frozen in liquid nitrogen. cAMP was extracted as described (Jung and Stateva, 2003) and quantitated using the EIA system-cAMP immunoassay (Amersham).
Adenylyl Cyclase Activity Assay
The assay is as described by Soloman et al. (1974) using sequential chromatography on Dowex cation exchange resin columns (The Dow Chemical Company, Midland, MI) and aluminum oxide. Briefly, 1 3 10 10 late log-phase cells were harvested by centrifugation and resuspended in ice-cold 25 mM Tri-HCl (pH 7.5). After two washes, the cells were resuspended in 1 ml of the same buffer in a 2 ml screw-cap tube and mixed with 0.4 ml of acid-washed glass beads (Sigma-Aldrich). Cells were lysed in a Mini-Beadbeater (Biospec Products, Inc., Bartlesville, OK) for six rounds of 2 min beating at 4 C with cooling on ice between rounds. Then 100 ml of the lysate was mixed with 100 ml of reaction mix containing 25 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , 20 mM creatine phosphate, 100 U/ml creatine phosphokinase, 1 mM cAMP, and 3 mCi of a-32 P-ATP. The reaction was incubated at 37 C for 10 min and then terminated by adding 200 ml of 2% SDS. Then, the mixture was centrifuged at 14,000 g for 10 min at 4 C. 32 P-cAMP from 200 ml of the supernatant was isolated for scintillation counting. 
